Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy

T.P. Hughes, S. Branford, D.L. White, J. Reynolds, R. Koelmeyer, J.F. Seymour, K. Taylor, C. Arthur, A. Schwarer, J. Morton, J. Cooney, M.F. Leahy, P. Rowlings, J. Catalano, M. Hertzberg, R. Filshie, A.K. Mills, K. Fay, S. Durrant, H. JanuszewiczDavid Joske, C. Underhill, S. Dunkley, K. Lynch, A. Grigg

    Research output: Contribution to journalArticlepeer-review

    143 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3965-3973
    Issue number10
    Publication statusPublished - 2008

    Cite this